4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-20-021287
Director bought 425,000 shares at $23.00 ($9,775,000)
- Director acquired 638,744 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
YAO TONY DUNG LING · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-15 | Conversion : show line 1 in the form | +2,864 | 2,864 | D | ||
| 2020-12-15 | Conversion : show line 2 in the form | +455,326 | 455,326 | I | ||
| 2020-12-15 | Conversion : show line 3 in the form | +180,554 | 635,880 | I | ||
| 2020-12-15 | Purchase : show line 4 in the form | +425,000 | $23.00 | $9,775,000 | 1,060,880 | I |
| Open-market purchases · 425,000 sh · avg $23.00 · $9,775,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-15 | Conversion : show line 5 in the form Series B Preferred Stock | −2,864 | 0 | D |
| 2020-12-15 | Conversion : show line 6 in the form Series B Preferred Stock | −455,326 | 0 | I |
| 2020-12-15 | Conversion : show line 7 in the form Series C Preferred Stock | −180,554 | 0 | I |
Loading xslF345X03/doc1.xml…